InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
38%
T+90 mean return
+0.5%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Jackson Blair Curtis, Deputy Chief Executive. Director active across 1 company, notably Alkermes plc.. Aggregated, 19 reports have been published. History available since 3 May 2021. The latest transaction was disclosed on 8 February 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations19 total
8,322 sharesOrdinary SharesSEC:0001127602-25-007314:0
9,694 sharesOrdinary SharesSEC:0001127602-25-006723:0
8,896 sharesOrdinary SharesSEC:0001127602-25-006035:0
34,393 sharesOrdinary SharesSEC:0001127602-25-003680:0
8,737 sharesOrdinary SharesSEC:0001127602-24-007139:0
9,693 sharesOrdinary SharesSEC:0001127602-24-006568:0
8,897 sharesOrdinary SharesSEC:0001127602-24-006171:0
36,835 sharesOrdinary SharesSEC:0001127602-24-004729:0
11,007 shares@ US$26.7713.2% of flowOrdinary SharesSEC:0001127602-24-004729:1
9,504 sharesOrdinary SharesSEC:0001127602-23-007181:0
8,722 sharesOrdinary SharesSEC:0001127602-23-006514:0
49,999 shares@ US$16.550.016% mcap42.4% of flowOrdinary SharesSEC:0001127602-22-012413:0
4,589 sharesOrdinary SharesSEC:0001127602-22-006309:0
2,375 sharesOrdinary SharesSEC:0001127602-22-005460:0
2,375 sharesOrdinary SharesSEC:0001127602-22-005460
6,884 shares0Ordinary SharesSEC:0001127602-21-025404:0
6,884 shares0Ordinary SharesSEC:0001127602-21-025404
34,503 shares@ US$18.1050.011% mcap28.8% of flowOrdinary SharesSEC:0001127602-21-015189:0
34,503 shares@ US$18.10528.8% of flowOrdinary SharesSEC:0001127602-21-015189
19 of 19 declarations
About Jackson Blair Curtis
Jackson Blair Curtis is the Executive Vice President and Chief Operating Officer of Alkermes plc. He plays a key role in managing the company's operations, contributing to the overall strategy and execution of initiatives. With expertise in the pharmaceutical sector, he is responsible for optimizing operational processes and improving efficiency. His leadership is essential for achieving the company's objectives and ensuring compliance with industry regulations.
